Spreading Awareness of Breast Cancer Advancements With UCSF Faculty

Published: Friday, Oct 19, 2018

We returned to San Francisco, California for a State of the Science SummitTM on Breast Cancer. The meeting covered the use of CDK4/6 inhibitors in metastatic hormone receptor-positive breast cancer, adjuvant and neoadjuvant HER2-targeted therapy in early-stage HER2-positive disease, immunotherapy in triple-negative disease, and more.
View Conference Coverage
Online CME Activities
Publication Bottom Border
Border Publication